{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-68",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013/regulation-68.json",
  "legislation": "uksi/2013/349",
  "legislation_title": "The National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-and-local-pharmaceutical-services-regulations-2013",
  "path": "regulation/68",
  "kind": "regulation",
  "number": "68",
  "heading": "Conditions relating to local resolution of disputes over terms of service",
  "text": "(1) It is a condition of the inclusion of each NHS chemist (C) in a pharmaceutical list by NHS England that C makes every reasonable effort to communicate and co-operate with NHS England with a view to resolving any dispute between C and NHS England relating to C's compliance with the terms of service under which C provides pharmaceutical services for NHS England.\n(2) NHS England may not vary or remove the condition imposed by virtue of paragraph (1).\n(3) For the purposes of paragraph (1), co-operation includes—\n(a) answering any questions which are reasonably put to C by NHS England within the timescales NHS England reasonably notifies; and\n(b) providing any information relating to the dispute which is reasonably required by NHS England within the timescales NHS England reasonably notifies.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Reg. 68(3) inserted (1.10.2026) by The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2026 (S.I. 2026/961), regs. 1(2), 7(2)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/349/regulation/68",
    "retrieved_at": "2026-10-29T01:03:55.705659+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}